7FD8

Thermostabilised full length human mGluR5-5M bound with L-quisqualic acid


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.80 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Starting Models: experimental
View more details

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformations.

Nasrallah, C.Cannone, G.Briot, J.Rottier, K.Berizzi, A.E.Huang, C.Y.Quast, R.B.Hoh, F.Baneres, J.L.Malhaire, F.Berto, L.Dumazer, A.Font-Ingles, J.Gomez-Santacana, X.Catena, J.Kniazeff, J.Goudet, C.Llebaria, A.Pin, J.P.Vinothkumar, K.R.Lebon, G.

(2021) Cell Rep 36: 109648-109648

  • DOI: https://doi.org/10.1016/j.celrep.2021.109648
  • Primary Citation of Related Structures:  
    7FD8, 7FD9, 7P2L

  • PubMed Abstract: 

    Metabotropic glutamate receptors (mGluRs) are dimeric G-protein-coupled receptors activated by the main excitatory neurotransmitter, L-glutamate. mGluR activation by agonists binding in the venus flytrap domain is regulated by positive (PAM) or negative (NAM) allosteric modulators binding to the 7-transmembrane domain (7TM). We report the cryo-electron microscopy structures of fully inactive and intermediate-active conformations of mGlu 5 receptor bound to an antagonist and a NAM or an agonist and a PAM, respectively, as well as the crystal structure of the 7TM bound to a photoswitchable NAM. The agonist induces a large movement between the subunits, bringing the 7TMs together and stabilizing a 7TM conformation structurally similar to the inactive state. Using functional approaches, we demonstrate that the PAM stabilizes a 7TM active conformation independent of the conformational changes induced by agonists, representing an alternative mode of mGlu activation. These findings provide a structural basis for different mGluR activation modes.


  • Organizational Affiliation

    IGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Metabotropic glutamate receptor 5
A, B
862Homo sapiensMutation(s): 7 
Gene Names: GRM5GPRC1EMGLUR5
Membrane Entity: Yes 
UniProt & NIH Common Fund Data Resources
Find proteins for P41594 (Homo sapiens)
Explore P41594 
Go to UniProtKB:  P41594
PHAROS:  P41594
GTEx:  ENSG00000168959 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP41594
Glycosylation
Glycosylation Sites: 1Go to GlyGen: P41594-1
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
Y01
Query on Y01

Download Ideal Coordinates CCD File 
E [auth A],
H [auth B]
CHOLESTEROL HEMISUCCINATE
C31 H50 O4
WLNARFZDISHUGS-MIXBDBMTSA-N
NAG
Query on NAG

Download Ideal Coordinates CCD File 
C [auth A],
F [auth B]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
QUS (Subject of Investigation/LOI)
Query on QUS

Download Ideal Coordinates CCD File 
D [auth A],
G [auth B]
(S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID
C5 H7 N3 O5
ASNFTDCKZKHJSW-REOHCLBHSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
QUS BindingDB:  7FD8 Ki: min: 22, max: 1.00e+4 (nM) from 7 assay(s)
EC50: min: 150, max: 630 (nM) from 4 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.80 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
RECONSTRUCTIONRELION3.1
MODEL REFINEMENTREFMAC5.8.0267

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Department of Biotechnology (DBT, India)IndiaDBT/PR12422/MED/31/287/2014
Science and Engineering Research Board (SERB)IndiaRJN-094/2017
Medical Research Council (MRC, United Kingdom)United KingdomMC-U105184322
Agence Nationale de la Recherche (ANR)FranceANR-17-CE18-0001
Agence Nationale de la Recherche (ANR)FranceANR-18-CE11-0001

Revision History  (Full details and data files)

  • Version 1.0: 2021-09-08
    Type: Initial release
  • Version 1.1: 2021-10-13
    Changes: Database references
  • Version 1.2: 2024-10-30
    Changes: Data collection, Refinement description, Structure summary